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summary, we propose this combination of truncal ecthyma-
gangrenosum-like lesions with bacterial colonization in the 
context of older age and immobility as a clinically distinct 
presentation or variant of BP.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Bullous pemphigoid (BP) is a chronic, autoimmune, 
subepidermal, blistering skin disease occurring predom-
inantly in elderly individuals in the fifth to seventh de-
cades of life  [1–4] . The incidence of BP appears to be equal 
in men and women. The onset of disease may be either 
subacute or acute, usually with widespread, tense blisters. 
Significant pruritus is frequently present. In some pa-
tients, the blisters arise following persistent urticarial le-
sions  [5] . Involvement of the mucosal surface has been 
reported in 10–30% of BP patients. Nevertheless, one of 
the indicating clinical criteria for BP seems to be the lack 
of mucosal involvement  [3, 6, 7] .
 BP is a result of a specific autoimmune antibody re-
sponse directed towards the hemidesmosomal BP anti-
gens BP230 and BP180  [8–12] . IgG autoantibodies bind to 
the skin basement membrane and activate complement. 
Activation of the complement system is thought to play a 
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 Abstract 
 Bullous pemphigoid (BP) is a chronic, autoimmune, subepi-
dermal blistering skin disease with varied clinical presenta-
tions. Diagnosis is based on the clinical picture, histopatho-
logical findings, and direct and indirect immunofluores-
cence studies. In unclear cases, ELISA or Western blot analysis 
helps to establish a definite diagnosis by the detection of
immunoglobulin G autoantibodies specific for the hemi-
desmosomal BP antigens BP230 and BP180. We report 3
cases of BP with an as yet not characterized, distinctive
ecthyma-gangrenosum-like presentation. Patients were fe-
male, above 80 years of age, physically immobile, and skin 
lesions showed truncal localization and bacterial coloniza-
tion. Factors contributing to physical immobility were a high 
body mass index, psychiatric disease, sedative medication 
and rheumatic disease. The clinical picture resembled ecthy-
ma gangrenosum but lacked systemic infection with  Pseudo-
monas aeruginosa. Lesional bacteriological studies revealed 
 Staphylococcus  aureus and/or  P. aeruginosa. Diagnosis proved 
challenging in all cases. Suspicion has to be high, and repeat-
ed diagnostic procedures and additional laboratory studies 
may be necessary to establish a definitive diagnosis of BP. In 
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critical role in attracting inflammatory cells to the base-
ment membrane. These are postulated to release prote-
ases, which degrade hemidesmosomal proteins and lead 
to blister formation. 
 Diagnosis is usually based on the clinical presentation, 
the histology and the results of direct (DIF) and indirect 
immunofluorescence (IIF) studies. Histologically, the 
blisters occur at the dermal-epidermal junction, and
eosinophils are characteristically present in human pa-
tients’ blisters. DIF demonstrates deposits of IgG in 70–
90% and complement C3 deposition in 90–100% of pa-
tients in a linear pattern at the dermal-epidermal junc-
tion. This pattern is not specific for BP and may be seen 
in cicatricial pemphigoid and epidermolysis bullosa ac-
quisita. BP can be differentiated from these conditions by 
incubating the patient’s skin biopsy sample in 1 mol/l salt 
prior to performing the DIF technique for cleavage 
through the lamina lucida. DIF on salt-split skin reveals 
IgG on the blister roof in patients with BP. IIF studies 
document the presence of IgG circulating autoantibodies 
in the patient’s serum that target components of the skin 
basement membrane. In our laboratory we use monkey 
and guinea pig esophagus as substrate. First, patient se-
rum is applied to monkey and guinea pig esophagus sec-
tions. Then, a secondary fluorescence-labeled anti-im-
munoglobulin antibody is used, and the result is visual-
ized. In selected cases, ELISA and Western blot analysis 
are additionally performed to detect autoantibodies 
against BP180 or BP230  [6, 13] . Antigenic epitopes and 
subdomains could recently be identified, and autoreac-
tive T cell responses have been characterized  [14–17] . 
Prognosis and disease activity correlate with serum levels 
of the autoantibodies to BP180 in patients with BP  [9, 18] .
 There is a typical delay between onset of the disease 
and diagnosis of BP, which is partly due to a varied clini-
cal presentation of BP. There are several distinct clinical 
presentations of BP, which have so far been described: 
generalized bullous form, vegetative form  [19, 20] , vesicu-
lar form  [21] , generalized erythrodermic form  [22, 23] , 
urticarial form, localized (usually pretibial) form  [2, 24] 
and nodular form  [25–28] .
 We report 3 patients with a distinct and hitherto un-
reported distinctive clinical presentation, characterized 
by ecthyma-gangrenosum-like lesions on the trunk ( ta-
ble 1 ). In most of our patients, BP was not the initial di-
agnosis taken into consideration. A high suspicion rate 
and repeated diagnostic procedures led to the definitive 
diagnosis of BP ( table 2 ). All cases involved bacterial col-
onization, possibly favored by physical immobility. The 
aim of this case series is to establish a profile of patients 
with this peculiar clinical presentation of BP.
 Case Presentation 
 Case 1  
 An 80-year-old female patient presented with multiple dis-
seminated, sharply circumscribed, superficial to profound ulcers, 
measuring up to 15 cm in diameter, coated with yellowish to 
greenish, adherent fibrinous scabs ( fig. 1 ), which had appeared 7 
months ago. The lesions were most pronounced on the back and 
were exceedingly painful and itchy. There were no blisters. The 
clinical differential diagnosis covered ecthyma contagiosum, ec-
thyma gangrenosum, vasculitis, unspecific pyoderma and other 
autoimmune diseases. The wound swab culture showed repeat-
edly  Staphylococcus aureus. There was no improvement with an-
tibiotic therapy (first amoxicillin/clavulanic acid and cefepime, 
then adjusted to flucloxacillin following an antibiogram). Histol-
ogy showed an intraepithelial pustule with a mainly eosinophilic 
Table 1. P atient characteristics including age, sex, concomitant illnesses, medication and duration of disease on admission
Case Age,
years
Sex Concomitant disease Medication Duration of 
disease, months
1 80 female coronary artery disease, arterial hyperten-
sion, diabetes mellitus type 2, BMI 35.6,
renal insufficiency, chronic depression 
insulin, lisinopril, pantoprazole,
citalopram, acetylsalicylic acid
7
2 86 female coronary artery disease, arterial hyperten-
sion, multiple cerebral chronic ischemic
lesions (with vertigo, chronic depression, 
parkinsonism)
clopidogrel, pravastatin, nitrazepam, 
pantoprazole, ramipril, carbidopa/
levodopa
24
3 81 female arterial hypertension, diabetes mellitus
type 2, BMI 30.2, insomnia
amlodipine, diclofenac, zolpidem 1.5
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and discrete neutrophilic infiltrate and a perivascular infiltrate 
with lymphocytes and eosinophils ( fig.  2 ). The complete blood 
count revealed an eosinophilia of maximally 1.8  ! 10 3 /  l (nor-
mal range 0.00–0.70  ! 10 3 /  l). On DIF, linear deposits of IgG and 
C3 along the basal membrane were found. The IIF showed circu-
lating IgG autoantibodies directed at antigens within the base-
ment membrane zone. These findings led to the diagnosis of a BP 
with ecthyma-gangrenosum-like clinical appearance. Differen-
tial diagnoses of other autoimmune bullous diseases, in particu-
lar epidermolysis bullosa acquisita, were ruled out by lack of mu-
cosal affection and lack of typical distribution along mechani-
cally exposed sites. Following this diagnosis, we switched therapy 
from antibiotics to intravenous corticosteroids for 9 days followed 
by a combination therapy of nicotinamide 500 mg 3 times a day 
and doxycycline 100 mg twice a day. Topically we used steroids 
under adhesive dressings. As a result of this therapy, the ulcers 
were almost completely healed after 8 weeks, and the patient 
could be discharged. The therapy was continued until death, 
which occurred unfortunately soon after. 
 Case 2 
 The 86-year-old female patient had a 2-year history of a very 
itchy rash with very itchy, red papules on the arms and shoulders 
initially. These efflorescences multiplied and spread to the whole 
back and legs over the next months. There was no improvement 
achieved by topical and shortly administered systemic steroids. 
On admission to our hospital we observed multiple, disseminat-
ed, partly confluent, sharply circumscribed ulcers on the back, 
arms and legs. They ranged in size from 1 to 4 cm and were coat-
ed with thick brownish-black scabs. Neither blisters nor urticar-
ial eruptions were visible at admission. Our differential diagnoses 
were vasculitis, blistering autoimmune disease or ecthyma. His-
tology showed subepidermal blistering, spongiosis and mixed in-
filtrate. DIF was negative. However, IIF revealed circulating IgG 
autoantibodies binding to the dermoepidermal junction on mon-
key and guinea pig esophagus sections in a linear pattern. Addi-
tionally, a serum Western blot was positive for antibodies against 
the 230-kDa antigen. These results led to the diagnosis of BP with 
ecthyma-gangrenosum-like clinical appearance. Under systemic 
treatment with nicotinamide and vibramycin, and topical ste-
roids, the ulcers healed over the next 2 weeks almost completely 
up to discharge. To our knowledge, there has not been a relapse, 
even though our follow-up stopped 1 year after diagnosis. 
 Case 3  
 This 81-year-old female patient was admitted for further diag-
nostic tests and therapy because of itching skin lesions of 6 weeks’ 
duration. Initially there were blackish spots disseminated on the 
back and less so on the abdomen. On admission we found multiple 
erosions with a fibrinous coat and red surrounding skin mainly 
on the upper back but also disseminated over the lower back, but-
tocks, legs and abdomen. There were no blisters. The histology 
revealed an unspecific inflammatory reaction. The DIF was how-
ever specific for BP with IgG and C3 deposits in a linear fashion 
along the basal membrane. Epidermolysis bullosa acquisita as a 
differential diagnosis could be ruled out clinically because of no 
involvement of the mucosae and lack of typical distribution along 
mechanically exposed sites. Therapy with systemic corticoste-
roids and mycophenolate was initiated in combination with cip-
rofloxacin to treat the Gram-negative bacterium  Serratia  mar-
cescens, which grew from a swab. Under this therapy, the skin 
healed over the next 3 weeks without new efflorescences at dis-
charge and with no relapse until today. 
Table 2. D iagnostic findings including histology, DIF, IIF and additional diagnostic procedures such as Western blot analysis
Case Histology DIF IIF Other
1 superficial ulceration with bacte-
rial masses, dermal mainly eosin-
ophilic infiltrate
IgG deposits in a linear pattern at 
the epidermal basement mem-
brane, C3 deposits at the dermo-
epidermal junctional zone
circulating autoantibodies 
(IgG) against components 
of the basal membrane
peripheral blood eosin-
ophilia
2 eosinophilic spongiosis, as seen 
in the prebullous phase of BP
negative circulating autoantibodies 
(IgG) against components 
of the basal membrane 
Western blot: band at 
230 kDa; ELISA posi-
tive for recombinant 
BP230 
3 superficial ulceration of the epi-
dermis with bacterial masses,
inflammatory cell infiltrate,
containing eosinophils
linear IgG and C3 deposits at the 
epidermal basement membrane 
negative Western blot negative 
for bands at 230 and 
180 kDa
 Fig. 1. Clinical presentation of ecthyma-gangrenosum-like BP. 
Overview and close-up of patients 1 ( a ,  b ), 2 ( c ,  d ) and 3 ( e ,  f ) are 
shown. All patients present a similar picture with multiple dis-
seminated, sharply circumscribed, superficial to profound ulcers, 
measuring up to 1.5 cm in diameter, coated with yellowish to 
greenish, adherent fibrinous scabs, mainly located on the back.  
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 Fig. 2. Histological presentation of ecthyma-gangrenosum-like BP in patients 1 ( a ,  b ), 2 ( c ,  d ) and 3 ( e ,  f ). HE 
stains at low- and high-power magnification show partly unspecific changes and partly pathognomonic chang-
es for BP such as subepidermal blister formation and eosinophilic spongiosis. The histological observations are 
listed in detail in table 2. 
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 Discussion 
 We present 3 cases of BP with a clinically distinct pre-
sentation. The clinical picture of all patients was very 
much alike, with ecthyma-gangrenosum-like lesions on 
the trunk of elderly bedridden female patients. In all cas-
es, BP was not considered as first differential diagnosis, 
but rather ecthyma gangrenosum, necrotizing vasculitis, 
disseminated pyoderma gangrenosum and cutaneous T 
cell lymphoma were considered. Autoimmune bullous 
disease was only considered in the differential diagnosis 
with a low priority, while eventually proving to be the fi-
nal diagnosis. 
 Bacterial colonization seemed important: penetration 
of  Pseudomonas aeruginosa is facilitated by several ex-
tracellular products such as exoenzyme S, elastase, exo-
toxin A, alkaline protease, hemolysins and leucocidin. 
The enzymes elastase and exoenzyme S are important 
virulence factors by disrupting the epithelial barrier 
function. From studies of venous leg ulcers, it is well 
known that the presence of  P. aeruginosa can induce ul-
cer enlargement and/or cause delayed healing  [29, 30] . By 
a variety of exotoxins (e.g. hemolysins, proteases, leuco-
cidins),  S. aureus also leads to epithelial damage. The 
pathogenicity of  S. aureus is increased in the presence of 
anaerobic bacteria such as  P. aeruginosa  [29, 30] . We hy-
pothesize that the initial epidermal barrier disruption by 
the developing lesions of BP or scratching due to pruritus 
related to BP ( fig. 1 e, f) combined with physical immo-
bility predisposed the skin of the back in our patients
to extensive bacterial overgrowth with  P. aeruginosa 
 and/or  S. aureus , leading to delayed healing, enlarging 
wounds and diagnostic problems  [31, 32] .
 All patients were elderly women with impaired physi-
cal mobility ( table 3 ). It is conceivable that relevant phys-
ical immobility leads to occlusion favoring bacterial over-
growth of either primary bullous lesions of BP or second-
ary excoriations due to pruritus associated with BP. Only 
extended diagnostic workup with additional and repeat 
diagnostic tests led to the final diagnosis of BP. This hith-
erto undescribed clinical presentation for BP and the ini-
tially negative tests for BP in a majority of patients led to 
delayed diagnosis and delayed start of an effective treat-
ment ( table 2 )  [8, 11, 14] . 
 We propose that ecthyma-gangrenosum-like BP is yet 
one more distinct clinical presentation of BP observed on 
the trunk of elderly, bedridden female patients, and that 
it is associated with bacterial overgrowth, primarily with 
 P. aeruginosa and  S. aureus . Recognizing this form of BP 
is important, since a high suspicion rate, extended and 
repeated diagnostic procedures are prerequisites for es-
tablishing the diagnosis of BP. Once the diagnosis is 
made, appropriate therapy of secondary infection and of 
BP along the proposed guidelines  [33] will usually be suc-
cessful.
 
Table 3. T he factors of immobility contributing to delayed wound healing: rheumatic disease, obesity, sedatives, psychiatric disease 
and neurological disease
Case Rheumatic disease BMI Sedatives or medication
with sedative side effect
Psychiatric disorder Neurological disorder
1 none 36 citalopram chronic depression diabetic neuropathy
2 none 24 nitrazepam chronic depression vertigo, secondary parkinsonism
3 chronic posttraumatic pain of
left shoulder and right hip
30 zolpidem insomnia none
O besity was categorized by body mass index (BMI; weight/square height, kg/m2): BMI ^ 18.5 signifies underweight, BMI 18.5–24.9 
normal weight, BMI 25.0–29.9 overweight, BMI 30.0–39.9 obesity and BMI 640 extreme obesity.
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